In September 2013 the South African Institute for Drug-Free Sport (SAIDS) has reported an anti-doping rule violation against the Athlete Helga Mathee after her sample tested positive for the prohibited substance Betamethasone. After notification a provisional suspension was ordered. The Athlete filed a statement with evidence in her defence and was heard for the SAIDS Disciplinary Panel.
The Athlete stated, sustained by medical records of her doctor and physiotherapist, that she suffered from piriformis muscle syndrome which was treated through administration of celestone soluspan injections containing the substance betamethasone.
Due to the Athlete was previously treated without success with other medication. The celestone soluspan was administered on 23 May 2013. A TUE application made by the Athlete for the use of betamethasone was denied by SAIDS on 22 August 2013.
The Panel concludes that the Athlete was incorrectly advised that the substance would not linger long in her system before the competition and that the substance was used as treatment for her medical condition. The Panel finds that the Athlete and her practitioner had made some effort to research use of the medication, including internet search but failed to act with utmost care.
Without intention to enhance her sport performance the SAIDS Disciplinary Panel decides on 12 September 2013 to impose a 3 month period of ineligibility on the Athlete. The sanction will start on the date of the SAIDS notification to apply for a retroactively TUE, i.e. on 1 August 2013.
